2020 Global Health Care Outlook
Laying a foundation for the future
Rising health care costs. Changing patient demographics. Evolving consumer expectations. New market entrants. Complex health and technology ecosystems.
The digital hospital of the future
In 10 years, technology may change the face of global health care delivery
Learn how the digital hospital of the future can leverage technology to transform the future of health care delivery, including digital patient experience in this report developed by Deloitte US.
The future awakens
Life Sciences and Health Care Predictions 2022
The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. These are some of our predictions that, if they come true, will shake up the life sciences and health care industry.
Healthcare and Life Sciences Predictions 2020
A bold future?
The Deloitte Center for Health Solutions has revealed a bold vision for the Healthcare and Life Sciences sector in 2020. The report, which launched at the 2014 FT Global Pharmaceutical and Biotechnology Conference, set outs ten provocative predictions for 2020.
How COVID-19 is challenging orthodoxies in airport customer experience
The pandemic is paving the way for a new normal where airports will need to challenge traditional orthodoxies in how they serve their customers and meet the needs of their employees.
Executing the COVID-19 recovery
A guide for governments for reopening and restoring their economies
Governments are on the frontlines of the COVID crisis. In the coming months, they will be focused on balancing health and economic impacts; promoting economic health for individuals, businesses, and other sectors; and reopening the economy with an eye towards a better future.
2020 Global life sciences outlook
Creating new value | Building blocks for the future
Gene therapies, intelligent drug discovery and development, consumer wearables, telemedicine, and more—what are some of the drivers transforming the life sciences sector? How can biopharma and medtech organizations create new value in 2020, while tackling various challenges?